These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6983693)

  • 41. Purification and characterization of a thymocyte growth factor. 1. Purification.
    Talaev VYu ; Shuvaeva TM; Lipkin VM; Yarilin AA; Shichkin VP
    Biomed Sci; 1991; 2(5):511-4. PubMed ID: 1840839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a tumor inhibitory factor in rat ascites fluid.
    Levine AE; Hamilton DA; Yeoman LC; Busch H; Brattain MG
    Biochem Biophys Res Commun; 1984 Feb; 119(1):76-82. PubMed ID: 6704134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [T-lymphocyte precursors--the target cells of thymocyte growth factor].
    Protsak EA; Shichkin VP; Iarilin AA
    Biull Eksp Biol Med; 1989 Apr; 107(4):462-4. PubMed ID: 2785826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution.
    Richmond A; Thomas HG
    J Cell Biochem; 1988 Feb; 36(2):185-98. PubMed ID: 3356754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells.
    Piacibello W; Severino A; Stacchini A; Aglietta M
    Haematologica; 1991; 76(6):460-6. PubMed ID: 1820982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Separation of the transforming growth factor from cells of murine sarcoma induced by polymeric film].
    Kishkina VB; StavrovskaiaAA
    Biull Eksp Biol Med; 1985 Sep; 100(9):332-4. PubMed ID: 3862433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
    Petit-Koskas E; Génot E; Lawrence D; Kolb JP
    Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus-transformed B lymphocytes produce low molecular mass molecules with autocrine growth factor and competence factor activity.
    Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M; Falcone G
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):449-54. PubMed ID: 1335948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2.
    Devi MA; Das NP
    Cancer Lett; 1993 May; 69(3):191-6. PubMed ID: 8513446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
    Liu C; Tsao MS; Grisham JW
    Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
    Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
    J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
    Eid J; Ebert RF; Gesell MS; Spivak JL
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
    Bowen DL; Ambrus JL; Fauci AS
    J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
    Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
    J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A growth-modifying factor from cell lines of human malignant origin.
    Rounds DE
    Cancer Res; 1970 Dec; 30(12):2847-51. PubMed ID: 5494570
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.
    Imam SA; Taylor CR
    Anticancer Res; 1996; 16(4A):1727-32. PubMed ID: 8712691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dependency of human T lymphocyte colony formation on soluble factors produced by accessory or tumor cells.
    Winkelstein A
    J Immunol; 1983 Jun; 130(6):2715-9. PubMed ID: 6602178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.